Clindamycin is a lincosamide antibiotic used to treat infections caused by susceptible bacteria. It is a semi-synthetic derivative of lincomycin and exhibits both antibacterial and anti-acne properties. Clindamycin works by binding to the 50S subunit of the bacterial ribosome, thereby inhibiting protein synthesis at an early stage. It is particularly effective against gram-positive and anaerobic bacteria.
Microbiology: Aerobic gram-positive cocci: Staphylococcus aureus, Staphylococcus epidermidis (including penicillinase and non-penicillinase producing strains), Streptococci, Pneumococci Anaerobic gram-negative bacilli: Bacteroides species, Fusobacterium species Anaerobic gram-positive non-spore forming bacilli: Propionibacterium species, Eubacterium species, Actinomyces species Anaerobic and microaerophilic gram-positive cocci: Peptococcus species, Peptostreptococcus species, microaerophilic streptococci, Clostridium perfringens